NAD + is revealed to be a metabolic signal that preserves an epigenetic mark central to trained immunity by inhibiting the histone demethylase KDM5a (see related Research Article by Jin et al. ).
No takes yet. Share an insight, caveat, or question.
Mhlanga et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: